499 related articles for article (PubMed ID: 17535834)
21. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
[TBL] [Abstract][Full Text] [Related]
22. Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study.
Darweesh SKL; Wolters FJ; Postuma RB; Stricker BH; Hofman A; Koudstaal PJ; Ikram MK; Ikram MA
JAMA Neurol; 2017 Dec; 74(12):1431-1438. PubMed ID: 28973176
[TBL] [Abstract][Full Text] [Related]
23. Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson's disease.
Jones JD; Burroughs M; Apodaca M; Bunch J
Neuropsychology; 2020 Jan; 34(1):24-30. PubMed ID: 31219297
[TBL] [Abstract][Full Text] [Related]
24. Cognitive impairment in Parkinson's disease.
Cosgrove J; Alty JE; Jamieson S
Postgrad Med J; 2015 Apr; 91(1074):212-20. PubMed ID: 25814509
[TBL] [Abstract][Full Text] [Related]
25. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability.
Cooper JA; Sagar HJ; Jordan N; Harvey NS; Sullivan EV
Brain; 1991 Oct; 114 ( Pt 5)():2095-122. PubMed ID: 1933236
[TBL] [Abstract][Full Text] [Related]
26. Cognitive impairment and dementia in Parkinson's disease.
Pagonabarraga J; Kulisevsky J
Neurobiol Dis; 2012 Jun; 46(3):590-6. PubMed ID: 22484304
[TBL] [Abstract][Full Text] [Related]
27. Memory and executive function impairment predict dementia in Parkinson's disease.
Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
[TBL] [Abstract][Full Text] [Related]
28. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
[TBL] [Abstract][Full Text] [Related]
29. Domain-specific cognitive impairment in non-demented Parkinson's disease psychosis.
Hinkle JT; Perepezko K; Bakker CC; Dawson TM; Johnson V; Mari Z; Marvel CL; Mills KA; Pantelyat A; Pletnikova O; Rosenthal LS; Shepard MD; Stevens DA; Troncoso JC; Wang J; Pontone GM
Int J Geriatr Psychiatry; 2018 Jan; 33(1):e131-e139. PubMed ID: 28509347
[TBL] [Abstract][Full Text] [Related]
30. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A
Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647
[TBL] [Abstract][Full Text] [Related]
31. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up.
Domellöf ME; Ekman U; Forsgren L; Elgh E
Acta Neurol Scand; 2015 Aug; 132(2):79-88. PubMed ID: 25644230
[TBL] [Abstract][Full Text] [Related]
32. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
[TBL] [Abstract][Full Text] [Related]
33. [Dementia and mild cognitive impairment in Parkinson's disease: a review].
Bocanegra Y; Trujillo-Orrego N; Pineda D
Rev Neurol; 2014 Dec; 59(12):555-69. PubMed ID: 25501454
[TBL] [Abstract][Full Text] [Related]
34. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease.
York MK; Dulay M; Macias A; Levin HS; Grossman R; Simpson R; Jankovic J
J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):789-95. PubMed ID: 17965146
[TBL] [Abstract][Full Text] [Related]
35. Computerized testing in Parkinson's disease: Performance deficits in relation to standard clinical measures.
Flannery SL; Jowett T; Garvey A; Cutfield NJ; Machado L
J Clin Exp Neuropsychol; 2018 Dec; 40(10):1062-1073. PubMed ID: 29978753
[TBL] [Abstract][Full Text] [Related]
36. Cognitive impairment is common in Parkinson's disease without dementia in the early and middle stages in a Han Chinese cohort.
Wu Q; Chen L; Zheng Y; Zhang C; Huang L; Guo W; Fang Y; Zhou H; Liu Y; Chen J; Qian H; Xian W; Zeng J; Li J; Liu Z; Pei Z
Parkinsonism Relat Disord; 2012 Feb; 18(2):161-5. PubMed ID: 21975261
[TBL] [Abstract][Full Text] [Related]
37. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
[TBL] [Abstract][Full Text] [Related]
38. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
Pedersen KF; Larsen JP; Tysnes OB; Alves G
JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
[TBL] [Abstract][Full Text] [Related]
39. Evaluating the performance of the Montreal Cognitive Assessment in early stage Parkinson's disease.
Kletzel SL; Hernandez JM; Miskiel EF; Mallinson T; Pape TL
Parkinsonism Relat Disord; 2017 Apr; 37():58-64. PubMed ID: 28189463
[TBL] [Abstract][Full Text] [Related]
40. Sleep spindles in Parkinson's disease may predict the development of dementia.
Latreille V; Carrier J; Lafortune M; Postuma RB; Bertrand JA; Panisset M; Chouinard S; Gagnon JF
Neurobiol Aging; 2015 Feb; 36(2):1083-90. PubMed ID: 25442116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
